Combination therapies for traumatic brain injury: Prospective considerations

Journal of Neurotrauma

Volumn 26, Issue 6, 2009, Pages 925-939

  Margulies, Susan ^a,c   Hicks, Ramona ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical trials; Head injury; In vitro and in vivo models; Injury mechanisms; Intervention

Indexed keywords

CITICOLINE; CYCLOSPORIN A; DIZOCILPINE; ERYTHROPOIETIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROPROTECTIVE AGENT; PROGESTERONE; SODIUM CHLORIDE; STEROID; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CLINICAL STUDY; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; EXPERIMENTAL DESIGN; FOOD AND DRUG ADMINISTRATION; HUMAN; INDUCED HYPOTHERMIA; MEDICAL RESEARCH; MYOPATHY; NONHUMAN; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; REVIEW; SCREENING; STATISTICS; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOMEDICAL RESEARCH; BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RESEARCH; RESEARCH DESIGN;

EID: 67849135779     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0794     Document Type: Review

References (173)

1. Adams, J.H., Graham, D.I., and Gennarelli, T.A. (1983). Head injury in man and experimental animals: neuropathology. Acta Neurochir. Suppl. (Wien.) 32, 15-30.
2. Adams, J.H., Graham, D.I., Murray, L.S., and Scott, G. (1982). Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann. Neurol, 12, 557-563.
3. Adibhatla, R.M., and Hatcher, J.F. (2002). Citicoline mechanisms and clinical efficacy in cerebral ischemia. J. Neurosci. Res. 70, 133-139.
4. Adibhatla, R.M., and Hatcher, J.F. (2005). Cytidine 50- diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem. Res. 30, 15-23.
5. Ahmed, S.M., Rzigalinski, B.A., Willoughby, K.A., Sitterding, H.A., and Ellis, E.F. (2000). Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J. Neurochem. 74, 1951-1960.
6. Alessandri, B., Rice, A.C., Levasseur, J., DeFord, M., Hamm, R.J., and Bullock, M.R. (2002). Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats. J. Neurotrauma 19, 829-841.
7. Allen, J.W., Knoblach, S.M., and Faden, A.I. (1999). Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase- 3-dependent apoptosis. FASEB J. 13, 1875-1882.
8. Aronowski, J., Strong, R., Shirzadi, A., and Grotta, J.C. (2003). Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke 34, 1246-1251.
9. Arundine, M., Aarts, M., Lau, A., and Tymianski, M. (2004). Vulnerability of central neurons to secondary insults after in vitro mechanical stretch. J. Neurosci. 24, 8106-8123.
10. Atkins, C.M., Oliva, A.A., Jr., Alonso, O.F., Chen, S., Bramlett, H.M., Hu, B.R., and Dietrich, W.D. (2007). Hypothermia treatment potentiates ERK1/2 activation after traumatic brain injury. Eur. J. Neurosci. 26, 810-819.
11. Bahr, B.A., Kessler, M., Rivera, S., Vanderklish, P.W., Hall, R.A., Mutneja, M.S., Gall, C., and Hoffman, K.B. (1995). Stable maintenance of glutamate receptors and other synaptic components in long-term hippocampal slices. Hippocampus 5, 425-439.
12. Baranova, A., Wei, E., Ueda, Y., Sholley, M., Kontos, H., and Povlishock, J. (2008). Cerebral vascular responsiveness after experimental traumatic brain injury: the beneficial effects of delayed hypothermia combined with superoxide dismutase administration. J. Neurosurg. 109, 502-509.
13. Baulieu, E.E., and Schumacher, M. (1997). Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves. Mult. Scler. 3, 105-112.
14. Bendel, O., Langmoen, I.A., and von Euler, G. (2004). Crush injury induces NMDA-receptor-dependent delayed nerve cell death in rat entorhinal-hippocampal slice cultures. Brain Res. 1025, 35-42.
15. Brain Trauma Foundation. (2007). Guidelines for the management of severe head injury. J. Neurotrauma 24(Suppl. 1), S1- S106.
16. Bramlett, H.M., Dietrich, W.D., Green, E.J., and Busto, R. (1997). Chronic histopathological consequences of fluid-percussion brain injury in rats: effects of post-traumatic hypothermia. Acta Neuropathol. 93, 190-199.
17. Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., Itri. L.M., and Cerami, A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.
18. Buchs, P.A., Stoppini, L., and Muller, D. (1993). Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures. Brain Res. Dev. Brain Res. 71, 81-91.
19. Caeser, M., and Aertsen, A. (1991). Morphological organization of rat hippocampal slice cultures. J. Comp. Neurol. 307, 87- 106.
20. Camacho-Arroyo, I., Pasapera, A.M., and Cerbon, M.A. (1996). Regulation of progesterone receptor gene expression by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit. Neurosci. Lett. 214, 25-28.
21. Camacho-Arroyo, I., Perez-Palacios, G., Pasapera, A.M., and Cerbon, M.A. (1994). Intracellular progesterone receptors are differentially regulated by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit. J. Steroid Biochem. Mol. Biol. 50, 299-303.
22. +]i in NG108-15 cells subjected to high strain rate deformation and chemical hypoxia: an in vitro model for neural trauma. J. Neurotrauma 13, 395-407.
23. Centers for Disease Control and Prevention. (2000). Vital statistics. From http://www.cdc.gov/nchs/fastats/stroke.htm. Chen, J., Zhang, Z.G., Li, Y., Wang, Y., Wang, L., Jiang, H., Zhang, C., Lu, M., Katakowski, M., Feldkamp, C.S., and Chopp, M. (2003). Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53, 743-751.
24. Chen, S.F., Hung, T.H., Chen, C.C., Lin, K.H., Huang, Y.N., Tsai, H.C., and Wang, J.Y. (2007). Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci. 81, 288-298.
25. Cherian, L., Goodman, J.C., and Robertson, C. (2007). Neuroprotection with erythropoietin administration following con- trolled cortical impact injury in rats. J. Pharmacol. Exp. Ther. 322, 789-794.
26. Chong, Z.Z., Kang, J.Q., and Maiese, K. (2003a). Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspasemediated pathways. Br. J. Pharmacol. 138, 1107-1118.
27. Chong, Z.Z., Lin, S.H., Kang, J.Q., and Maiese, K. (2003b). Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71, 659-669.
28. Clark, R.S., Carcillo, J.A., Kochanek, P.M., Obrist, W.D., Jackson, E.K., Mi, Z., Wisneiwski, S.R., Bell, M.J., and Marion, D.W. (1997). Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 41, 1284- 1292; discussion 1292-1293.
29. Clifton, G.L., Jiang, J.Y., Lyeth, B.G., Jenkins, L.W., Hamm, R.J., and Hayes, R.L. (1991). Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11, 114-121.
30. Cochrane. (2005). The Cochrane Collaboration Brain Injury Review. Brain Injury, Cochrane Collaboration. Cohadon, F., Richer, E., and Poletto, B. (1982). [A precursor of phospholipids in the treatment of severe traumatic comas]. Neurochirurgie 28, 287-290.
31. Collin, C., Miyaguchi, K., and Segal, M. (1997). Dendritic spine density and LTP induction in cultured hippocampal slices. J. Neurophysiol 77, 1614-1623.
32. Corwin, H.L., Gettinger, A., Fabian, T.C., May, A., Pearl, R.G., Heard, S., An, R., Bowers, P.J., Burton, P., Klausner, M.A., and Corwin, M.J. (2007). Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med. 357, 965-976.
33. Corwin, H.L., Gettinger, A., Pearl, R.G., Fink, M.P., Levy, M.M., Shapiro, M.J., Corwin, M.J., and Colton, T. (2002). Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288, 2827-2835.
34. Corwin, H.L., Gettinger, A., Rodriguez, R.M., Pearl, R.G., Gubler, K.D., Enny, C., Colton, T., and Corwin, M.J. (1999). Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit. Care Med. 27, 2346-2350.
35. Cotelle, P. (2006). Patented HIV-1 integrase inhibitors (1998- 2005). Recent Patents Anti-Infect. Drug Disc. 1, 1-15.
36. Cucchiara, B., and Kasner, S.E. (2001). Use of statins in CNS disorders. J. Neurol. Sci. 187, 81-89.
37. De Simoni, A., Griesinger, C.B., and Edwards, F.A. (2003). Development of rat CA1 neurones in acute versus organotypic slices: role of experience in synaptic morphology and activity. J. Physiol. 550, 135-147.
38. Digicaylioglu, M., Bichet, S., Marti, H.H., Wenger, R.H., Rivas, L.A., Bauer, C., and Gassmann, M. (1995). Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA 92, 3717-3120.
39. Doppenberg, E.M., Choi, S.C., and Bullock, R. (2004). Clinical trials in traumatic brain injury: lessons for the future. J. Neurosurg. Anesthesiol. 16, 87-94.
40. Doyle, J.A., Davis, D.P., and Hoyt, D.B. (2001). The use of hypertonic saline in the treatment of traumatic brain injury. J. Trauma 50, 367-383.
41. Edwards,M.E.,Wang, S.S., andGood, T.A. (2001).Role of viscoelastic properties of differentiated SH-SY5Y human neuroblastoma cells in cyclic shear stress injury. Biotechnol. Prog. 17, 760-767.
42. Elkin, B.S., and Morrison, B., 3rd (2007). Region-specific tolerance criteria for the living brain. Stapp Car Crash J. 51, 127-138.
43. Emery, D.G., Lucas, J.H., and Gross, G.W. (1987). The sequence of ultrastructural changes in cultured neurons after dendrite transection. Exp. Brain Res. 67, 41-51.
44. Engel, D.C., Slemmer, J.E., Vlug, A.S., Maas, A.I., and Weber, J.T. (2005). Combined effects of mechanical and ischemic injury to cortical cells: secondary ischemia increases damage and decreases effects of neuroprotective agents. Neuropharmacology 49, 985-995.
45. + channels. Eur. J. Neurosci. 12, 4007-4016.
46. Faden, A.I. (2002). Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr. Opin. Neurol. 15, 707-712.
47. Ferrand-Drake, M., Zhu, C., Gido, G., Hansen, A.J., Karlsson, J.O., Bahr, B.A., Zamzami, N., Kroemer, G., Chan, P.H., Wieloch, T., and Blomgren, K. (2003). Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. J. Neurochem. 85, 1431-1442.
48. Feuerstein, G.Z., Zaleska, M.M., Krams, M., Wang, X., Day, M., Rutkowski, J.L., Finklestein, S.P., Pangalos, M.N., Poole, M., Stiles, G.L., Ruffolo, R.R., and Walsh, F.L. (2008). Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J. Cereb. Blood Flow Metab. 28, 217-219.
49. Fisher, M., Feurstein, G., Howells, D.W., Hurn, P.D., Kent, T.A., Savitz, S.I., Lo, E.H. (2009). Update on stroke theraphy academic industry roundtable preclinical recommendations. Stroke DOI: 10.1161/STROKEAHA.108.541128.
50. Floyd, C.L., and Lyeth, B.G. (2007). Astroglia: important mediators of traumatic brain injury. Prog. Brain Res. 161, 61-79.
51. Floyd, R.A. (1999). Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222, 236-245.
52. Foda, M.A., and Marmarou, A. (1994). A new model of diffuse brain injury in rats. Part II: Morphological characterization. J. Neurosurg. 80, 301-313.
53. Folbergrova, J., Li, P.A., Uchino, H., Smith, M.L., and Siesjo, B.K. (1997). Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp. Brain Res. 114, 44-50.
54. Frantseva, M.V., Kokarovtseva, L., Naus, C.G., Carlen, P.L.,
55. MacFabe, D., and Perez, J.L. Velazquez, J.L. (2002). Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J. Neurosci. 22, 644-653.
56. Fukui, S., Signoretti, A., Dunbar, J.G., and Marmarou, A. (2003). The effect of cyclosporin A on brain edema formation following experimental cortical contusion. Acta Neurochir. Suppl. 86, 301-303.
57. Gahwiler, B.H. (1984). Development of the hippocampus in vitro: cell types, synapses and receptors. Neuroscience 11, 751-760.
58. Genazzani, A.R., Petraglia, F., and Purdy, R.H. (1996). The brain: source and target for sex steroid hormones. 1st Tuscania Conference on Reproductive Medicine, Pisa, Italy. Parthenon Pub. Group: New York.
59. Glass, T.F., Reeves, B., and Sharp, F.R. (2002). Modeling both the mechanical and hypoxic features of traumatic brain injury in vitro in rats. Neurosci. Lett. 328, 133-136.
60. Glass, T.F., Reeves, B. and Sharp, F.R. (2004). The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture. Neurobiol. Dis. 17, 378-384.
61. Gorio, A., Madaschi, L., Di Stefano, B., Carelli, S., Di Giulio, A.M., De Biasi, S., Coleman, T., Cerami, A., and Brines, M. (2005). Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc. Natl. Acad. Sci. USA 102, 16379-16384.
62. Graham, D.I., Gennarelli, T., and McIntosh, T.K. (2002). Trauma. Greenfields's Neuropathology. D.I. Graham and P.L. Lantos (eds), Arnold: New York, pp. 823-882.
63. Graham, D.I., McIntosh, T.K., Maxwell, W.L., and Nicoll, J.A. (2000). Recent advances in neurotrauma. J. Neuropathol. Exp. Neurol. 59, 641-651.
64. Grasso, G. (2001). Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J. Neurosurg. Sci. 45, 7-14.
65. Gross, G.W., and Higgins, M.L. (1987). Cytoplasmic damage gradients in dendrites after transection lesions. Exp. Brain Res. 67, 52-60.
66. Gross, G.W., Lucas, J.H., and Higgins, M.L. (1983). Laser microbeam surgery: ultrastructural changes associated with neurite transection in culture. J. Neurosci. 3, 1979-1993.
67. Hall, E.D., McCall, J.M., and Means, E.D. (1994). Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28, 221-268.
68. Hansson, M.J., Persson, T., Friberg, H., Keep, M.F., Rees, A., Wieloch, T., and Elmer, E. (2003). Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res. 960, 99-111.
69. Harrington, M., and Carpenter, C.C. (2000). Hit HIV-1 hard, but only when necessary. Lancet 355, 2147-2152.
70. Hartel, R., and Matus, A. (1997). Cytoskeletal maturation in cultured hippocampal slices. Neuroscience 78, 1-5.
71. Hickenbottom, S.L., and Grotta, J. (1998). Neuroprotective therapy. Semin. Neurol. 18, 485-492.
72. Holtgrave, D.R. (2005). Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? Int. J. STD AIDS 16, 777-781.
73. Hong, S.J., and Chang, C.C. (1995). Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA. J. Physiol. 482, 283-290.
74. Jung, K.H., Chu, K., Jeong, S.W., Han, S.y., Lee, S.T., Kim, J.Y., Kim, M., and Roh, J.K. (2004). HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35, 1744-1749.
75. Juul, S.E., Stallings, S.A., and Christensen, R.D. (1999). Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr. Res. 46, 543-547.
76. Kaibara, T., Sutherland, G.R., Colbourne, F., and Tyson, R.L. (1999). Hypothermia: depression of tricarboxylic acid cycle flux and evidence for pentose phosphate shunt upregulation. J. Neurosurg. 90, 339-347.
77. Kamada, M., Li, R.Y., Hashimoto, M., Kakuda, M., Okada, H., Koyanagi, Y., Ishizuka, T., and Yawo, H. (2004). Intrinsic and spontaneous neurogenesis in the postnatal slice culture of rat hippocampus. Eur. J. Neurosci. 20, 2499-2508.
78. Kanagy, N.L., Perrine, M.F., Cheung, D.K., and Walker, B.R. (2003). Erythropoietin administration in vivo increases vascular nitric oxide synthase expression. J. Cardiovasc. Pharmacol. 42, 527-533.
79. Katano, H., Fujita, K., Kato, T., Asai, K., Kawamura, Y., Masago, A., and Yamada, K. (1999). Traumatic injury in vitro induces IEG mRNAs in cultured glial cells, suppressed by co-culture with neurons. Neuroreport 10, 2439-2348.
80. Kennedy, J.E., Clement, P.F., and Curtiss, G. (2003). WAIS-III processing speed index scores after TBI: the influence of working memory, psychomotor speed and perceptual processing. Clin. Neuropsychol. 17, 303-307.
81. Koizumi, H., and Povlishock, J.T. (1998). Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 89, 303-309.
82. LaPlaca, M.C., and Thibault, L.E. (1997). An in vitro traumatic injury model to examine the response of neurons to a hydrodynamically- induced deformation. Ann. Biomed. Eng. 25, 665-677.
83. Laufs, U., La Fata, V., Plutzky, J., and Liao, J.K. (1998). Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135.
84. Lea, P.M.T., Custer, S.J., Stoica, B.A., and Faden, A.I. (2003). Modulation of stretch-induced enhancement of neuronal NMDA receptor current by mGluR1 depends upon presence of glia. J. Neurotrauma 20, 1233-1249.
85. Lea, P.M., Custer, S.J., Vicini, S., and Faden, A.I. (2002). Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol. Biochem. Behav. 73, 287-298.
86. Lefkopoulou, M., and Ryan, L. (1993). Global tests for multiple binary outcomes. Biometrics 49, 975-988.
87. Levin, H.S. (1991). Treatment of postconcussional symptoms with CDP-choline. J. Neurol. Sci. 103(Suppl.), S39-S42.
88. Limmroth, V., Lee, W.S., and Moskowitz, M.A. (1996). GABAAreceptor- mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br. J. Pharmacol. 117, 99-104.
89. Li, P.A., Kristian, T., He, Q.P., and Siesjo, B.K. (2000). Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp. Neurol. 165, 153-163.
90. Lo, E.H., Wang, X., and Cuzner, M.L. (2002). Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J. Neurosci. Res. 69, 1-9.
91. Lu, M., and Tilley, B.C. (2001). Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial. Stat. Med. 20, 1891-1901.
92. Lu, D., Goussev, A., Chen, J., Pannu, P., Li, Y., Mahmood, A., and Chopp, M. (2004a). Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J. Neurotrauma 21, 21-32.
93. Lu, D., Mahmood, A., Goussev, A., Schallert, T., Qu, C., Zhang, Z.G., Li, Y., Lu, M., and Chopp, M. (2004b). Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J. Neurosurg. 101, 813-821.
94. Lu, D., Mahmood, A., Qu, C., Goussev, A., Lu, M., and Chopp, M. (2004c). Atorvastatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. J. Neurosurg. 101, 822-825.
95. Lu, D., Mahmood, A., Qu, C., Goussev, A., Schallert, T., and Chopp, M. (2005). Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J. Neurotrauma 22, 1011-1017.
96. Lu, D., Qu, C., Goussev, A., Jiang, H., Lu, C., Schallert, T., Mahmood, A., Chen, J., Li, Y., and Chopp, M. (2007). Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J. Neurotrauma 24, 1132-1146.
97. Lucas, J.H., Emery, D.G., Higgins, M.L., and Gross, G.W. (1990). Neuronal survival and dynamics of ultrastructural damage after dendrotomy in low calcium. J. Neurotrauma 7, 169-192.
98. Lynch, J.R., Wang, H., McGirt, M.J., Floyd, J., Friedman, A.H., Coon, A.L., Blessing, R., Alexander, M.J., Graffagnino, C., Warner, D.S., and Laskowitz, D.T. (2005). Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36, 2024-2026.
99. Maas, A.I., Marmarou, A., Murray, G.D., Teasdale, S.G., and Steyerberg, E.W. (2007). Prognosis and clinical trial design in traumatic brain injury: the Impact study. J. Neurotrauma 24, 232-238.
100. Maas, A.I. (2001). Neuroprotective agents in traumatic brain injury. Expert Opin. Investig. Drugs 10, 753-767.
101. Mansfield, R.T., Schiding, J.K., Hamilton, R.L., and Kochanek, P.M. (1996). Effects of hypothermia on traumatic brain injury in immature rats. J. Cereb. Blood Flow Metab. 16, 244-252.
102. Marklund, N., Bakshi, A., Castelbuono, D.J., Conte, V., and McIntosh, T.K. (2006). Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr. Pharm. Des. 12, 1645-1680.
103. Marti, H.H., Bernaudin, M., Petit, E., and Bauer, C. (2000). Neuroprotection and Angiogenesis: Dual role of erythropoietin in brain ischemia. News Physiol. Sci. 15, 225-229.
104. May, M.T., Sterne, J.A., Costagliola, D., Sabin, C.A., Phillips, A.N., Justice, A.C., Dabis, F., Gill, J., Lundgren, J., Hogg, R.S., de Wolf, F., Fatkenheuer, G., Staszewski, S., d'Arminio Monforte, A., and Egger, M. (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet 368, 451-458.
105. Mbye, L.H., Singh, I.N., Carrico, K.M., Saatman, K.E., and Hall, E.D. (2009). Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 87-97.
106. McCauley, S.R., Levin, H.S., Vanier, M., Mazaux, J.M., Boake, C., Goldfader, P.R., Rockers, D., Butters, M., Kareken, D.A., Lambert, J., and Clifton, G.L. (2001). The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment. J. Neurol. Neurosurg. Psychiatry 71, 643-651.
107. McGirt, M.J., Lynch, J.R., Parra, A., Sheng, H., Pearlstein, R.D., Laskowitz, D.T., Pelligrino, D.A., and Warner, D.S. (2002). Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33, 2950-2956.
108. McIntosh, T.K., Smith, D.H., Meaney, D.F., Kotapka, M.J., Gennarelli, T.A., and Graham, D.I. (1996). Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 74, 315-342.
109. Mitsuyasu, R. (2002). Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients. J. Infect. Dis. 185(Suppl. 2), S115-S122.
110. Moppett, I.K. (2007). Traumatic brain injury: assessment, resuscitation and early management. Br. J. Anaesth. 99, 18-31.
111. Morganti-Kossmann, M.C., Satgunaseelan, L., Bye, N., and Kossmann, T. (2007). Modulation of immune response by head injury. Injury 38, 1392-1400.
112. Morrison, B., 3rd, Cater, H.L., Wang, C.C., Thomas, F.C., Hung, C.T., Ateshian, G.A., and Sundstrom, L.E. (2003). A tissue level tolerance criterion for living brain developed with an in vitro model of traumatic mechanical loading. Stapp Car Crash J. 47, 93-105.
113. Mukhin, A.G., Ivanova, S.A., Allen, J.W., and Faden, A.I. (1998). Mechanical injury to neuronal/glial cultures in microplates: role of NMDA receptors and pH in secondary neuronal cell death. J. Neurosci. Res. 51, 748-758.
114. Mukhin, A.G., Ivanova, S.A., Knoblach, S.M., and Faden, A.I. (1997). New in vitro model of traumatic neuronal injury: evaluation of secondary injury and glutamate receptormediated neurotoxicity. J. Neurotrauma 14, 651-663.
115. Narayan, R.K., Michel, M.E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M.B., Bullock, M.R., Choi, S.C., Clifton, G.L., Contant, C.F., Coplin, W.M., Dietrich, W.D., Ghajar, J., Grady, S.M., Grossman, R.G., Hall, E.D., Heetderks, W., Hovda, D.A., Jallo, J., Katz, R.L., Knoller, N., Kochanek, P.M., Maas, A.I., Majde, J., Marion, D.W., Marmarou, A., Marshall, L.F., Mc- Intosh, T.K., Miller, E., Mohberg, N., Muizelaar, J.P., Pitts, L.H., Quinn, P., Riesenfeld, G., Robertson, C.S., Strauss, K.I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M.D., Weinrich, M., Whyte, J., Wilberger, J., Young, A.B., and Yurkewicz, #L. (2002). Clinical trials in head injury. J. Neurotrauma 19, 503-557.
116. Palesch, Y.Y., Tilley, B.C., Sackett, D.L., Johnston, K.C., and Woolson, R. (2005). Applying a phase II futility study design to therapeutic stroke trials. Stroke 36, 2410-2414.
117. Panickar, K.S., Jayakumar, A.R., and Norenberg, M.D. (2002). Differential response of neural cells to trauma-induced free radical production in vitro. Neurochem. Res. 27, 161-166.
118. Panizzon, K.L., Shin, D., Frautschy, S., and Wallis, R.A. (1998). Neuroprotection with Bcl-2(20-34) peptide against trauma. Neuroreport 9, 4131-4136.
119. Pascual, J.L., Khwaja, K.A., Ferri, L.E., Giannias, B., Evans, D.C., Razek, T., Michel, R.P., and Christou, N.V. (2003). Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection. J. Trauma 54, 121-130; discussion 130-132.
120. Pasternak, J.J., and Lanier, W.L. (2007). Neuroanesthesiology review-2006. J. Neurosurg. Anesthesiol. 19, 70-92.
121. Peterson, K., Carson, S., and Carney, N. (2008). Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J. Neurotrauma 25, 62-71.
122. Povlishock, J.T., Becker, D.P., Cheng, C.L., and Vaughan, G.W. (1983). Axonal change in minor head injury. J. Neuropathol. Exp. Neurol. 42, 225-242.
123. Povlishock, J.T., and Katz, D.I. (2005). Update of neuropathology and neurological recovery after traumatic brain injury. J. Head Trauma Rehabil. 20, 76-94.
124. Povlishock, J.T. (1992). Traumaticallyinducedaxonal injury:pathogenesis and pathobiological implications. Brain Pathol. 2, 1-12.
125. Prough, D.S., Kramer, G.C., Uchida, T., Stephenson, R.T., Hellmich, H.L., and Dewitt, D.S. (2006). Effects of hypertonic arginine on cerebral blood flow and intracranial pressure after traumatic brain injury combined with hemorrhagic hypotension. Shock 26, 290-295.
126. Raghupathi, R. (2004). Cell death mechanisms following traumatic brain injury. Brain Pathol. 14, 215-222.
127. Reddy, D.S., and Kulkarni, S.K. (1996). Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl.) 128, 280-292.
128. Robain, O., Barbin, G., Billette de Villemeur, T., Jardin, L., Jahchan, T., and Ben-Ari, Y. (1994). Development of mossy fiber synapses in hippocampal slice culture. Brain Res. Dev. Brain Res. 80, 244-250.
129. Roberts, I., Schierhout, G., and Alderson, P. (1998). Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review [see comments]. J. Neurol. Neurosurg. Psychiatry 65, 729-733.
130. Saatman, K.E., Duhaime, A.-C., Bullock, R., Maas, A.I.R., Valadka, A., Manley, G.T., and Workshop Scientific Team and Advisory Panel Members (2008). Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 25, 719- 738.
131. Sahuquillo, J., and Vilalta, A. (2007). Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury. Curr. Pharm. Des. 13, 2310- 2322.
132. Salzwedel, K., Martin, D.E., and Sakalian, M. (2007). Maturation inhibitors: a new therapeutic class targets the virus structure. AIDS Rev. 9, 162-172.
133. Schouten, J.W. (2007). Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr. Opin. Crit. Care 13, 134-142.
134. Schwid, S.R., and Cutter, G.R. (2006). Futility studies: spending a little to save a lot. Neurology 66, 626-627.
135. Secades, J.J., and Lorenzo, J.L. (2006). Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp. Clin. Pharmacol. 28(Suppl. B), 1-56.
136. Serbest, G., Horwitz, J., and Barbee, K. (2005). The effect of poloxamer- 188 on neuronal cell recovery from mechanical injury. J. Neurotrauma 22, 119-132.
137. Seyfried, D., Han, Y., Lu, D., Chen, J., Bydon, A., and Chopp, M. (2004). Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J. Neurosurg. 101, 104-107.
138. Sieg, F., Wahle, P., and Pape, H.C. (1999). Cellular reactivity to mechanical axonal injury in an organotypic in vitro model of neurotrauma. J. Neurotrauma 16, 1197-1213.
139. Signoretti, S., Marmarou, A., Tavazzi, B., Dunbar, J., Amorini, A.M., Lazzarino, G., and Vagnozzi, R. (2004). The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. J. Neurotrauma 21, 1154-1167.
140. Smith, S.L., and Hall, E.D. (1996). Mild pre- and posttraumatic hypothermia attenuates blood-brain barrier damage following controlled cortical impact injury in the rat. J. Neurotrauma 13, 1-9.
141. Smith, D.H., Meaney, D.F., and Shull, W.H. (2003). Diffuse axonal injury in head trauma. J. Head Trauma Rehabil. 18, 307- 316.
142. Smith, D.H., Wolf, J.A., Lusardi, T.A., Lee, V.M., and Meaney, D.F. (1999). High tolerance and delayed elastic response of cultured axons to dynamic stretch injury. J. Neurosci. 19, 4263-4269.
143. Sofroniew, M.V. (2005). Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407.
144. Springborg, J.B., Ma, X., Rochat, P., Knudsen, G.M., Amtorp, O., Paulson, O.B., Juhler, M., and Olsen, N.V. (2002). A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br. J. Pharmacol. 135, 823-829.
145. STAIR-II (Stroke Therapy Academic Industry Roundtable II). (2001). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32, 1598-1606.
146. STAIR (Stroke Therapy Academic Industry Roundtable). (1999). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30, 2752- 2758.
147. Stein, D.G., Wright, D.W., and Kellermann, A.L. (2008). Does progesterone have neuroprotective properties? Ann. Emerg. Med. 51, 164-172.
148. Stoppini, L., Buchs, P.A., and Muller, D. (1993). Lesion-induced neurite sprouting and synapse formation in hippocampal organotypic cultures. Neuroscience 57, 985-994.
149. Strong, R., Grotta, J.C., and Aronowski, J. (2000). Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology 39, 515-522.
150. Suehiro, E., Ueda, Y., Wei, E.P., Kontos, H.A., and Povlishock, J.T. (2003). Posttraumatic hypothermia followed by slow rewarming protects the cerebral microcirculation. J. Neurotrauma 20, 381-390.
151. Sullivan, P.G., Rabchevsky, A.G., Waldmeier, P.C., and Springer, J.E. (2005). Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79, 231-239.
152. Sullivan, P.G., Thompson, M., and Scheff, S.W. (2000). Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp. Neurol. 161, 631-637.
153. Tecoma, E.S., Monyer, H., Goldberg, M.P., and Choi, D.W. (1989). Traumatic neuronal injury in vitro is attenuated by NMDA antagonists. Neuron 2, 1541-1545.
154. Temkin, N.R., Anderson, G.D., Winn, H.R., Ellenbogen, R.G., Britz, G.W., Schuster, J., Lucas, T., Newell, D.W., Mansfield, P.N., Machamer, J.E., Barber, J., and Dikmen, S.S. (2007). Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol. 6, 29-38.
155. Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A., and McIntosh, T.K. (2005). Lateral fluid percussion brain injury: a 15-year review and evaluation. J. Neurotrauma 22, 42-75.
156. Tilley, B.C., Palesch, Y.Y., Kieburtz, K., Ravina, B., Huang, P., Elm, J.J., Shannon, K., Wooten, G.F., Tanner, C.M., and Goetz, G.C. (2006). Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology 66, 628-633.
157. Tommasino, C., and Picozzi, V. (2007). Volume and electrolyte management. Best Pract. Res. Clin. Anaesthesiol. 21, 497-516.
158. Toni, N., Stoppini, L., and Muller, D. (1997). Staurosporine but not chelerythrine inhibits regeneration in hippocampal organotypic cultures. Synapse 27, 199-207.
159. Tortorici, M.A., Kochanek, P.M., and Poloyac, S.M. (2007). Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit. Care Med. 35, 2196- 2204.
160. Tseng, M.Y., Czosnyka, M., Richards, H., Pickard, J.D., and Kirkpatrick, P.J. (2005). Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36, 1627-1632.
161. U.S. Food and Drug Administration. (2008). Retrieved 6/16/08, 2008, from http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfccfr/CFRSearch.cfm.
162. Unterberg, A.W., Stover, J., Kress, B., and Kiening, K.L. (2004). Edema and brain trauma. Neuroscience 129, 1021-1029.
163. Vink, R., McIntosh, T.K., Weiner, M.W., and Faden, A.I. (1987). Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study. J. Cereb. Blood Flow Metab. 7, 563-571.
164. Wang, H., Lynch, J.R., Song, P., Yang, H.J., Yates, R.B., Mace, B., Warner, D.S., Guyton, J.R., and Laskowitz, D.T. (2007). Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp. Neurol. 206, 59-69.
165. Wang, L., Zhang, Z., Wang, Y., Zhang, R., and Chopp, M. (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737.
166. Warach, S., Pettigrew, L.C., Dashe, J.F., Pullicino, P., Lefkowitz, D.M., Sabounjian, L., Harnett, K., Schwiderski, U., and Gammans, R. (2000). Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann. Neurol. 48, 713-722.
167. Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., and Hommel, U. (2001). Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7, 687-692.
168. Werner, C., and Engelhard, K. (2007). Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99, 4-9. Wright, D.W., Bauer, M.E., Hoffman, S.W., and Stein, D.G. (2001). Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J. Neurotrauma 18, 901-909.
169. Wright, D.W., Kellermann, A.L., Hertzberg, V.S., Clark, P.L., Frankel, M., Goldstein, F.C., Salomone, J.P., Dent, L.L., Harris, O.A., Ander, D.S., Lowery, D.W., Patel, M.M., Denson, D.D., Gordon, A.B., Wald, M.M., Gupta, S., Hoffman, S.W., and Stein, D.G. (2007). ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 49, 391-402, 402e1-2.
170. Xiao, G., Wei, J., Yan, W., Wang, W., and Lu, Z. (2008). Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 12, R61.
171. Yeni, P.G., Hammer, S.M., Carpenter, C.C., Cooper, D.A., Fischl, M.A., Gatell, J.M., Gazzard, B.G., Hirsch, M.S., Jacobsen, D.M., Katzenstein, D.A., Montaner, J.S., Richman, D.D., Saag, M.S., Schechter, M., Schooley, R.T., Thompson, M.A., Vella, S., and Volberding, P.A. (2002). Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 288, 222-235.
172. Yi, J.H., and Hazell, A.S. (2006). Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem. Int. 48, 394-403.
173. Zimmer, J., and Gahwiler, B.H. (1984). Cellular and connective organization of slice cultures of the rat hippocampus and fascia dentata. J. Comp. Neurol. 228, 432-446.